Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Sandoz-proposed-biosimilar-rituximab-accepted-for-review-by-the-FDA-25099005/?utm_source=whatsapp&utm_medium=social&utm_campaign=share